BIIB

2
Biogen
Stock :NASDAQ
: Healthcare
: Drug Manufacturers—General
Miracle Viewer
  13/06/2024 10:00 GMT+2
1.20
237.82748
218.5795
-0.400
0.001
0.051
0.043

Ruota il tuo smartphone per vedere un grafico migliore
Ruota il tuo smartphone per vedere un grafico migliore

Operativity type

LONG
Profit %
93.71 %
Timeframe
H 1
Duration
15
BIIB
Sector: Health Technology
Industry: Biotechnology
Employees: 9100
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.